PACTR201505001128346已完成未知
Clinical efficacy and safety of products marketed in Egypt under the claim of being natural nutraceuticals for male enhancement
Faculty of Pharmacy, Alexandria university0 个研究点目标入组 50 人开始时间: 2015年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 Year(s) 至 60 Year(s)（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Hypertension
- •Cardiovascular disease
- •Liver diseases
- •Kidney diseases
研究者
相似试验
已完成
4 期
Study on drugs used in peripheral neuropathy in elderly patientsCTRI/2018/02/011720Dr Alok Singh60
未知
2 期
Investigation of the efficacy/safety and clinical dose of TAK-390MR for Erosive Esophagitis - A Phase II/III, Stratified-Randomized, Double-Blind, Parallel-Group, Multicenter Study on Efficacy and Safety of TAK-390MR by Comparison with AG-1749 in Patients with Erosive EsophagitisSubjects endoscopically diagnosed erosive esophagitisJPRN-jRCT2080220529Takeda Pharmaceutical Company Limited850
撤回
不适用
Clinical investigation of the safety and efficacy of ALIMAXX-B biliary stent for bile duct obstructioCBD obstructionmalignant biliary obstruction10018008NL-OMON31943Alveolus, Inc.10
已完成
3 期
Evaluation of the Clinical Safety and Efficacy of Suprimun in Renal Transplant RecipientsComparative Interventional Treatment for reduceing the renal transplant rejection.kidney transplant rejectionIRCT2013012612274N1Vice-Chancellor for Research, Shahid Beheshti University of Medical Sciences100
已完成
3 期
Evaluation of the Clinical Safety and Efficacy of Suprimun in Renal Transplant RecipientsComparative Interventional Treatment for reduceing the renal transplant rejection.kidney transplant rejectionIRCT2014072118548N1Research Deputy of Kermanshah University Of Medical Sciences60